Susquehanna International Group, LLP Nymox Pharmaceutical Corp Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.19 - $0.49 $435 - $1,123	2,293 Added 5.79%	41,914 $7,000
Q1 2023 May 16, 2023	SELL	$0.33 - $0.5 $3,325 - $5,038	-10,077 Reduced 20.28%	39,621 $13,000
Q4 2022 Feb 14, 2023	BUY	$0.28 - $0.74 $4,054 - $10,716	14,482 Added 41.12%	49,698 $15,000
Q3 2022 Nov 14, 2022	BUY	$0.22 - $0.61 $1,911 - $5,300	8,689 Added 32.76%	35,216 $15,000
Q2 2022 Aug 15, 2022	SELL	$0.38 - $1.41 $14,529 - $53,912	-38,236 Reduced 59.04%	26,527 $12,000
Q1 2022 May 16, 2022	SELL	$1.21 - $2.0 $1,482 - $2,450	-1,225 Reduced 1.86%	64,763 $82,000
Q4 2021 Feb 14, 2022	SELL	$0.95 - $2.1 $22,848 - $50,507	-24,051 Reduced 26.71%	65,988 $86,000
Q3 2021 Nov 15, 2021	BUY	$1.3 - $2.23 $71,600 - $122,821	55,077 Added 157.53%	90,039 $185,000
Q2 2021 Aug 11, 2021	BUY	$1.46 - $2.48 $2,122 - $3,605	1,454 Added 4.34%	34,962 $55,000
Q1 2021 May 17, 2021	BUY	$2.22 - $3.39 $10,478 - $16,000	4,720 Added 16.4%	33,508 $74,000
Q4 2020 Feb 16, 2021	SELL	$1.84 - $2.83 $2,476 - $3,809	-1,346 Reduced 4.47%	28,788 $71,000
Q3 2020 Nov 16, 2020	BUY	$2.3 - $3.66 $28,536 - $45,409	12,407 Added 69.99%	30,134 $74,000
Q2 2020 Aug 14, 2020	SELL	$2.1 - $4.6 $663,045 - $1.45 Million	-315,736 Reduced 94.68%	17,727 $63,000
Q1 2020 May 15, 2020	BUY	$1.69 - $3.88 $387,547 - $889,753	229,318 Added 220.19%	333,463 $780,000
Q4 2019 Feb 14, 2020	BUY	$1.73 - $2.42 $156,167 - $218,453	90,270 Added 650.59%	104,145 $229,000
Q3 2019 Nov 14, 2019	BUY	$1.41 - $2.12 $4,273 - $6,425	3,031 Added 27.95%	13,875 $26,000
Q1 2019 May 15, 2019	SELL	$1.57 - $2.71 $189,199 - $326,579	-120,509 Reduced 91.74%	10,844 $21,000
Q4 2018 Feb 14, 2019	SELL	$1.31 - $2.53 $205,946 - $397,743	-157,211 Reduced 54.48%	131,353 $172,000
Q3 2018 Nov 14, 2018	BUY	$2.46 - $3.7 $193,582 - $291,160	78,692 Added 37.5%	288,564 $710,000
Q2 2018 Aug 14, 2018	BUY	$3.12 - $4.33 $285,058 - $395,610	91,365 Added 77.1%	209,872 $705,000
Q1 2018 May 15, 2018	SELL	$3.09 - $4.43 $209,094 - $299,769	-67,668 Reduced 36.35%	118,507 $501,000
Q4 2017 Feb 14, 2018	BUY	$3.29 - $4.06 $352,178 - $434,602	107,045 Added 135.28%	186,175 $614,000
Q3 2017 Nov 14, 2017	BUY	$3.36 - $4.02 $265,876 - $318,102	79,130	79,130 $302,000

Others Institutions Holding NYMX

# of Institutions

Shares Held

150K

Call Options Held

Put Options Held

View Full List

About NYMOX PHARMACEUTICAL CORP

Ticker NYMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,265,000
Market Cap $42.9M
Description
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...

More about NYMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account